Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 8,685 shares at $29.64 ($258K) on 2024-07-17, disclosed to the SEC on 2024-07-19.
Open-market sale of $258k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.64 | 8,175 | $242K | 94.0% |
| 2 | $30.55 | 510 | $16K | 6.0% |
| Total | $29.69 avg | 8,685 | $258K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |